Press

Former minister and researcher at the University of Chile, Dr. Flavio Salazar, explained that Oncobiomed’s immunological therapies ‘make the response much more precise and effective, and reduce adverse effects’.

Chilean cancer vaccine reaches China and Brazil. Based on its successful results, the company Oncobiomed is sharing its experience to promote its technologies and collaborate with international researchers and research centres.

The Chilean cancer vaccine is possible. Dr. Flavio Salazar comments on Oncobiomed’s advances in the development of immunotherapies and the challenges for their scaling up and technology transfer.

In-depth interview on the results of the TAPCells melanoma vaccine, Oncobiomed’s technological advances, and the positive impact these treatments have on the people who receive them.

Patient shares how he recovered from a terminal cancer with therapy that re-educates cells. Dr. Flavio Salazar developed a treatment that involves extracting and training immune system cells to attack tumours.

A unique strategy in the world: a skin cancer vaccine is being tested as a tool to prevent Alzheimer’s disease. By injecting tumour cells, the immune system can be strengthened, thus preventing the development of this neurodegenerative disease.

TAPCells is an advanced therapy developed by the Oncobiomed company, which has emerged as a promising treatment for patients diagnosed with cancer and is based on personalised vaccines that stimulate the immune system.

A therapeutic vaccine developed at the University of Chile will be tested on patients with gallbladder cancer in Valdivia. Region de los Rios concentrates the highest number of diagnosed cases globally.